CLINICAL AND PATHOGENETIC RATIONALE FOR DIFFERENTIATED TREATMENT OF CHRONIC CATARRHAL GINGIVITIS IN TYPE 2 DIABETES

Authors

  • To’ychiev Vaxobiddin Xo’jabek o’g’li Assistant, Department of Dentistry, Zarmed University

Keywords:

gingivitis, type 2 diabetes, glycaemic control, biofilm, inflammation, differentiated treatment

Abstract

Objective. To formulate a differentiated approach to chronic catarrhal gingivitis in adults with type 2 diabetes. Materials and methods. A narrative synthesis compared gingivitis definitions, evidence on inflammatory mediators, periodontal diabetes consensus recommendations and adjunctive plaque control research. Findings were assessed by population, clinical endpoint and relevance to treatment selection. Results. The proposed approach separates confirmation of gingivitis from metabolic assessment and links treatment intensity to plaque retention, inflammation, self-care capacity and early response. Three clinical matrices support diagnostic recording, intervention selection and reassessment. Published inflammatory data illustrate the need to distinguish biological association from a treatment indication. Conclusion. Differentiation should strengthen local biofilm control and coordination of diabetes care while reserving additional treatment for a defined clinical need. Persistent inflammation requires renewed assessment of diagnosis and adherence.

References

Trombelli L., Farina R., Silva C.O., Tatakis D.N. Plaque-induced gingivitis: Case definition and diagnostic considerations. J Clin Periodontol. 2018;45(Suppl 20):S44–S67. doi:10.1111/jcpe.12939.

Sanz M., Ceriello A., Buysschaert M. et al. Scientific evidence on the links between periodontal diseases and diabetes: Consensus report and guidelines of the joint workshop by the International Diabetes Federation and the European Federation of Periodontology. J Clin Periodontol. 2018;45(2):138–149. doi:10.1111/jcpe.12808.

Andriankaja O.M., Barros S.P., Moss K. et al. Levels of serum interleukin (IL)-6 and gingival crevicular fluid of IL-1beta and prostaglandin E(2) among non-smoking subjects with gingivitis and type 2 diabetes. J Periodontol. 2009;80(2):307–316. doi:10.1902/jop.2009.080385.

Taylor J.J., Preshaw P.M., Lalla E. A review of the evidence for pathogenic mechanisms that may link periodontitis and diabetes. J Clin Periodontol. 2013;40(Suppl 14):S113–S134. doi:10.1111/jcpe.12059.

Chapple I.L.C., Van der Weijden F., Doerfer C. et al. Primary prevention of periodontitis: managing gingivitis. J Clin Periodontol. 2015;42(Suppl 16):S71–S76. doi:10.1111/jcpe.12366.

Scottish Dental Clinical Effectiveness Programme. Gingivitis. Prevention and Treatment of Periodontal Diseases in Primary Care. https://periodontalcare.sdcep.org.uk/guidance/managing-disease/gingivitis/ (accessed 26 October 2026).

James P., Worthington H.V., Parnell C. et al. Chlorhexidine mouthrinse as an adjunctive treatment for gingival health. Cochrane Database Syst Rev. 2017;3:CD008676. doi:10.1002/14651858.CD008676.pub2.

Scottish Dental Clinical Effectiveness Programme. Oral hygiene aids. Prevention and Treatment of Periodontal Diseases in Primary Care. https://periodontalcare.sdcep.org.uk/guidance/treatment-components/managing-risk-factors/oral-hygiene/oral-hygiene-aids/ (accessed 26 October 2026).

Scottish Dental Clinical Effectiveness Programme. Establishing a treatment plan. Prevention and Treatment of Periodontal Diseases in Primary Care. https://periodontalcare.sdcep.org.uk/guidance/planning-treatment/establishing-a-treatment-plan/ (accessed 26 October 2026).

Downloads

Published

2026-10-26